News
UCSF researchers found the cancer drugs letrozole and irinotecan may reverse Alzheimer's effects, reducing tau protein clumps ...
Early-onset Alzheimer's, affecting individuals under 65, presents unique challenges with memory, thinking, and daily ...
Lecanemab presentations to include long-term Clarity AD data, real-world treatment insights, and a subcutaneous formulation ...
New program combines IV-delivered TRACER™ capsid with bifunctional payload to silence APOE in carriers of the high-risk APOE4 ...
The model reveals that more connected brain regions are more prone to damage, while isolated areas remain resilient. This approach offers a powerful framework for understanding disease progression and ...
Researchers are investigating blood-based biomarkers like pTau217 for Alzheimer’s detection, offering a less invasive ...
Lexington, Massachusetts Tuesday, July 22, 2025, 18:00 Hrs [IST] ...
9h
News Medical on MSNMath model sheds light on Alzheimer’s spreadMathematics may not be the first thing people associate with Alzheimer’s disease research. But for Pedro Maia, an assistant ...
16h
IFLScience on MSNCOVID-19 Can Lead To Build Up Of Alzheimer’s-Linked Protein Clumps In Eyes And BrainPeople with Alzheimer’s have high levels of amyloid-β in their brains, but the team also learned that this was the case in ...
Newborns and individuals with Alzheimer's disease have been found to share an unusual biological feature: both show high ...
Elecsys pTau181 is the first In Vitro Diagnostic Regulation (IVDR) certified test to rule out Alzheimer’s associated amyloid ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results